GLOBUS MEDICAL INCGMED财报
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
GMED Q4 2025 Key Financial Metrics
营收
$826.4M
毛利润
$565.3M
营业利润
$169.3M
净利润
$140.6M
毛利率
68.4%
营业利润率
20.5%
净利率
17.0%
同比增长
25.7%
EPS
$1.01
资金流向
GLOBUS MEDICAL INC Q4 2025 财务摘要
GLOBUS MEDICAL INC reported revenue of $826.4M (up 25.7% YoY) for Q4 2025, with a net profit of $140.6M (up 430.4% YoY) (17.0% margin). Cost of goods sold was $261.1M, operating expenses totaled $396.0M.
核心财务指标
| 总营收 | $826.4M |
|---|---|
| 净利润 | $140.6M |
| 毛利率 | 68.4% |
| 营业利润率 | 20.5% |
| 报告期 | Q4 2025 |
营收拆解
GLOBUS MEDICAL INC Q4 2025 revenue of $826.4M breaks down across 3 segments, led by Other at $391.8M (47.4% of total).
| 业务分部 | 营收 | 占比 |
|---|---|---|
| Other | $391.8M | 47.4% |
| Nevro Merger Agreement | $293.6M | 35.5% |
| Enabling Technologies | $141.0M | 17.1% |
GLOBUS MEDICAL INC 年度营收
GLOBUS MEDICAL INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.9B). Click any linked year to see what changed vs the prior 10-K.
GLOBUS MEDICAL INC 季度营收与净利润历史
GLOBUS MEDICAL INC quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 季度 | 营收 | 营收同比 | 净利润 | 净利率 |
|---|---|---|---|---|
| Q4 2025 | $826.4M | +25.7% | $140.6M | 17.0% |
| Q3 2025 | $769.0M | +22.9% | $119.0M | 15.5% |
| Q2 2025 | $745.3M | +18.4% | $202.8M | 27.2% |
| Q1 2025 | $598.1M | -1.4% | $75.5M | 12.6% |
| Q4 2024 | $657.3M | +6.6% | $26.5M | 4.0% |
| Q3 2024 | $625.7M | +63.1% | $51.8M | 8.3% |
| Q2 2024 | $629.7M | +115.9% | $31.8M | 5.0% |
| Q1 2024 | $606.7M | +119.3% | $-7.1M | -1.2% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $606.7M | $629.7M | $625.7M | $657.3M | $598.1M | $745.3M | $769.0M | $826.4M |
| 同比增长 | 119.3% | 115.9% | 63.1% | 6.6% | -1.4% | 18.4% | 22.9% | 25.7% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $4.94B | $4.99B | $5.09B | $5.25B | $4.71B | $4.96B | $5.10B | $5.30B |
| 总负债 | $1.02B | $1.02B | $1.02B | $1.07B | $623.1M | $665.4M | $696.8M | $729.5M |
| 股东权益 | $3.92B | $3.98B | $4.07B | $4.18B | $4.09B | $4.30B | $4.40B | $4.57B |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $52.4M | $54.3M | $203.7M | $210.3M | $177.3M | $77.9M | $249.7M | $248.6M |